Serina Therapeutics
SER
31 hedge funds and large institutions have $2.67M invested in Serina Therapeutics in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 2 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
0% more funds holding
Funds holding: 31 → 31 (0)
0% less ownership
Funds ownership: 0.36% → 0.36% (-0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
3% less capital invested
Capital invested by funds: $2.75M → $2.67M (-$87K)
75% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$13.2K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.54K |
| 3 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$339 |
| 4 |
TCOV
Trust Company of Vermont
Brattleboro,
Vermont
|
+$68 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SWIG
Strategic Wealth Investment Group
Louisville,
Kentucky
|
-$15.4K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$6K |
| 3 |
BlackRock
New York
|
-$4.66K |
| 4 |
Millennium Management
New York
|
-$4.66K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.85K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| – | -$23 | -1 | -10% |
|
|
TCOV
27
Trust Company of Vermont
Brattleboro,
Vermont
| – | +$68 | +3 | New |
|
SER Hedge Fund Activity: Q3 2022 in Review
31 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q3 2022, worth a combined $2.67M — down 3.2% from $2.75M a quarter earlier.
Fund positioning in SER was balanced in Q3 2022: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 8 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $13.2K. The largest seller was Strategic Wealth Investment Group, cutting an estimated $15.4K.
- 31 institutional investors held Serina Therapeutics (SER) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $2.67M of Serina Therapeutics stock for Q3 2022, down 3.2% quarter-over-quarter.
- 2 funds opened new Serina Therapeutics positions in Q3 2022 and 2 closed out, a net change of 0 holders.
- The largest Serina Therapeutics buyer in Q3 2022 was Virtu Financial, an estimated $13.2K added.
- The largest Serina Therapeutics seller in Q3 2022 was Strategic Wealth Investment Group, an estimated $15.4K sold.
Based on aggregated 13F filings for Q3 2022.